Status:
COMPLETED
Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack
Lead Sponsor:
Yale University
Collaborating Sponsors:
Robert Wood Johnson Foundation
ResMed Foundation
Conditions:
Transient Ischemic Attack
Sleep Apnea
Eligibility:
All Genders
45+ years
Phase:
PHASE2
Brief Summary
Generalist physicians in the outpatient setting care for 80% of the 300,000 patients who have transient ischemic attacks (TIA) annually in the United States. Despite existing secondary prevention ther...
Eligibility Criteria
Inclusion
- transient ischemic attack -
Exclusion
- age \<45 years; respiratory distress or known sleep-disordered breathing; chronic obstructive pulmonary disease (COPD) requiring oxygen; pregnancy; time from symptom onset to beginning of study intervention 72 hours; life expectancy \<6 months; cognitive impairment (Mini-Mental Status Exam\<20); inability to provide informed consent; inability to communicate in English; residence outside the greater New Haven area; or any condition where the monitoring required by the study would constitute a risk to the patient or impair his or her care.
- \-
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00251290
Start Date
November 1 2004
End Date
September 1 2007
Last Update
March 3 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of St. Raphael
New Haven, Connecticut, United States, 06510
2
Yale-New Haven Hospital
New Haven, Connecticut, United States, 06520
3
VA Connecticut Healthcare System, West Haven Campus
West Haven, Connecticut, United States, 06516